JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 37 No. 1 5-11
© 1996 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Delforge, J.
Right arrow Articles by Syrota, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Delforge, J.
Right arrow Articles by Syrota, A.

Quantitation of Benzodiazepine Receptors in Human Brain Using the Partial Saturation Method

Jacques Delforge, Laurent Spelle, Bernard Bendriem, Yves Samson, Michel Bottlaender, Sokratis Papageorgiou and André Syrota

Service Hospitalier Frédéric Joliot, Atomic Energy Commission, Orsay, France

Correspondence: For correspondence or reprints contact: Jacques Delforge, PhD, Service Hospitalier Frédéric Joliot, 4 Place du Général Leclerc, 91406 Orsay, France.

ABSTRACT

The in vivo quantification of the benzodiazepine receptor concentration in humans using PET and flumazenil (FMZ) is usually based on Scatchard analysis when the goal is to avoid blood sampling. The experimental protocols, however, include several (at least two) experiments with various specific activities in the same subject to obtain a range of bound ligand concentrations. Methods: We propose the partial saturation method, which is based on a natural decrease in bound ligand concentration after an FMZ injection with an average dose between a tracer dose and a saturation dose. An adequate range of bound ligand concentrations can thus be obtained from a single experiment. The free ligand concentration is estimated from the PET measurement in the pons after correction for the effect of the small receptor site concentration in this reference region. Results: The receptor concentration and affinity estimates obtained with this approach in six regions of interest agree with previously published values obtained by using more complex approaches. Receptor concentration appears to be insensitive to the uncertainties with regard to the receptor site concentration in the pons. Conclusion: The partial saturation protocol can be used to estimate both the benzodiazepine receptor concentration and the FMZ affinity in routine examinations in adults (or even in children) using a single 40-min experiment without blood sampling.

Key Words: benzodiazepine receptors • flumazenil • quantification • PET




This article has been cited by other articles:


Home page
BrainHome page
S. Bouvard, N. Costes, F. Bonnefoi, F. Lavenne, F. Mauguiere, J. Delforge, and P. Ryvlin
Seizure-related short-term plasticity of benzodiazepine receptors in partial epilepsy: a [11C]flumazenil-PET study
Brain, June 1, 2005; 128(6): 1330 - 1343.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
K. I. Bolla, U. D. McCann, and G. A. Ricaurte
Memory impairment in abstinent MDMA ("Ecstasy") users
Neurology, December 1, 1998; 51(6): 1532 - 1537.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1996 by the Society of Nuclear Medicine.